We’re Taking a Few Steps in a New Direction!
Effective 1 November 2026, the Licensing & Enforcement Department will temporarily operate from BoMRA Head Office as we transition to our new office. While our location is changing, our commitment to providing consistent, reliable and responsive regulatory services remains unchanged. During the transition, our direct telephone lines may be temporarily affected. Stakeholders can continue to […]
Emergency BRIMS System Upgrade and Anticipated Downtime
The Botswana Medicines Regulatory Authority (BoMRA) wishes to inform all stakeholders that an emergency upgrade of the Botswana Regulatory Information Management System (BRIMS) is being undertaken to update the PHP versions on the affected systems as part of ongoing efforts to maintain system security, stability, and reliability. The upgrade is scheduled to take place from […]
BoMRA Celebrates Academic Excellence at the 2026 University of Botswana Graduation Ceremony
The Botswana Medicines Regulatory Authority (BoMRA) is proud to have sponsored the BoMRA Prize at today’s University of Botswana Graduation Ceremony.Awarded annually by the University Senate, the prize recognises graduating students who demonstrate outstanding academic performance in the School of Biomedical Science and Pharmacy, achieving a minimum Cumulative Grade Point Average (CGPA) of 4.0, alongside […]
Brims Service Restoration: Please Verify Recent Transactions
Following scheduled power maintenance by the electricity provider in the Finance Park area, the BOMRA (Regulatory Information Management System (BRIMS) experienced instability and service interruptions from Saturday, 17 October to Sunday, 18 October 2026. Full service was restored on Monday, 19 October 2026. During this period, some transactions, submissions, or updates may not have been […]
Voluntary Recall Of Specified Batches Of Medicines Manufactured By Remedica Limited
The Botswana Medicines Regulatory Authority (BOMRA) wishes to inform the public and stakeholders of a voluntary recall received from Remedica Limited through Pharm Vision (Pty) Ltd concerning specified batches of the eight (8) products listed below. What members of the public should do? Members of the public who are in possession of any of the […]
Happy 60th Independence Day From BoMRA!
As Botswana celebrates 60 years of Independence, the Botswana Medicines Regulatory Authority (BoMRA) extends its warmest wishes to all our valued clients, stakeholders and partners. We wish you and your loved ones a peaceful, safe and enjoyable Independence holiday Please note that, in observance of the Independence Day holidays, BOMRA offices will be closed on […]
Registration Roadmap For Class A And Notifiable Medical Devices, Including In Vitro Diagnostics, Establishment Licensing, And Compliance Deadlines
The Botswana Medicines Regulatory Authority (BoMRA) wishes to inform all relevant stakeholders of the implementation of regulatory requirements for medical devices, including in vitro diagnostics (IVDs), under the Medical Device Regulatory Roadmap.The roadmap supports Botswana’s progressive strengthening of medical device regulation in line with internationally recognized regulatory principles. The framework aims to protect patients, healthcare […]
WHO and Botswana launch Good Clinical Practice (GCP) training of reviewers from Regulatory Authorities across the continent.
Gaborone, 21 September 2026 — The World Health Organization (WHO) and the Botswana Medicines Regulatory Authority (BoMRA) is hosting a Good Clinical Practice (GCP) capacity building (training) workshop aimed at strengthening research and development (R&D) in medicines, vaccines, and other health products through enhancing clinical trial regulatory systems across the African continent. The programme, organized […]
BoMRA joins the global healthcare community in commemorating World Patient Safety Day 2026 under the theme: “Safe care for noncommunicable diseases” Slogan: “Safe care for life!”
This year’s campaign highlights the importance of safe, quality and continuous care for people living with noncommunicable diseases (NCDs). At BoMRA, we remain committed to protecting patients by strengthening the safety, quality and monitoring of health products
Call For Submission Of Dossiers For Expedited Registration Of Veterinary Medicinal Products (VMPs)
The Botswana Medicines Regulatory Authority (BoMRA) invites interested principals, manufacturers and Marketing Authorisation Holders (MAHs) to submit dossiers for registration of veterinary medicinal products (VMPs) through the “reliance based” – expedited registration pathway. This initiative supports BoMRA’s ongoing efforts to enhance access to quality-assured, safe and effective veterinary medicines on the Botswana market.This pathway is […]